What is Dow Development Laboratories?
Dow Development Laboratories operates as a contract development and manufacturing organization (CDMO) specializing in pharmaceutical drug product development and testing services. The Northern California-based firm caters to pharmaceutical and biotech companies, offering a comprehensive suite of services including formulation development, analytical method validation, and clinical packaging. With a particular emphasis on topical products, Dow Development Laboratories aids clients in accelerating their drug products through development and regulatory approval pathways. The company's operations are FDA-registered and adhere to cGMP compliance, ensuring high-quality service delivery and transparent client communication.
How much funding has Dow Development Laboratories raised?
Dow Development Laboratories has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Dow Development Laboratories
PPP
Public-Private Partnership
What's next for Dow Development Laboratories?
The substantial capital infusion, particularly the recent strategic investment, signals a pivotal phase for Dow Development Laboratories. This funding is likely to fuel further expansion of its service offerings, potentially enhancing its capabilities in specialized areas like topical drug formulation and clinical trial support. The company may also look to scale its operational capacity to meet increasing demand from the pharmaceutical and biotech industries. Strategic partnerships and further technological advancements are probable avenues for growth, solidifying its position as a key player in the drug development ecosystem and enabling it to support a broader range of client needs in bringing innovative therapies to market.
See full Dow Development Laboratories company page
